Drug intelligence / Profile preview

Formula 3

Development stage
Unknown
Lead developer
Tetra Corporation
Modality
Small Molecules
Administration
Topical
01

Overview

Formula 3 is a topical antifungal solution developed by Tetra Corporation for the treatment of athlete's foot (tinea pedis) and ringworm. The product's active ingredient is 1% tolnaftate, a small molecule antifungal agent that has been FDA-approved for over 50 years. Formula 3 utilizes a patented technology that renders tolnaftate oil-soluble by using natural jojoba oil as the delivery vehicle. This in-solution formulation prevents the active ingredient from separating and facilitates rapid absorption into the skin, delivering the antifungal agent directly to the site of infection. It works by inhibiting the growth of dermatophyte fungi. Formula 3 is an over-the-counter (OTC) product and has received the American Podiatric Medical Association's Seal of Approval.

Brand names
Formula 3Formula3Formula-3
Other names
Formula 3 AntifungalFormula3 AntifungalFormula-3 AntifungalFormula 3 Topical SolutionFormula3 Topical SolutionFormula-3 Topical Solution
02

Targets

SQLE (Squalene monooxygenase)

Beyond the preview

Go deeper on Formula 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formula 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call